201 related articles for article (PubMed ID: 22918538)
1. Fragment screening of cyclin G-associated kinase by weak affinity chromatography.
Meiby E; Knapp S; Elkins JM; Ohlson S
Anal Bioanal Chem; 2012 Nov; 404(8):2417-25. PubMed ID: 22918538
[TBL] [Abstract][Full Text] [Related]
2. Fragment screening for drug leads by weak affinity chromatography (WAC-MS).
Ohlson S; Duong-Thi MD
Methods; 2018 Aug; 146():26-38. PubMed ID: 29378316
[TBL] [Abstract][Full Text] [Related]
3. Weak affinity chromatography as a new approach for fragment screening in drug discovery.
Duong-Thi MD; Meiby E; Bergström M; Fex T; Isaksson R; Ohlson S
Anal Biochem; 2011 Jul; 414(1):138-46. PubMed ID: 21352794
[TBL] [Abstract][Full Text] [Related]
4. Advances with weak affinity chromatography for fragment screening.
Tsopelas F; Tsantili-Kakoulidou A
Expert Opin Drug Discov; 2019 Nov; 14(11):1125-1135. PubMed ID: 31380703
[No Abstract] [Full Text] [Related]
5. Weak affinity chromatography for evaluation of stereoisomers in early drug discovery.
Duong-Thi MD; Bergström M; Fex T; Svensson S; Ohlson S; Isaksson R
J Biomol Screen; 2013 Jul; 18(6):748-55. PubMed ID: 23479356
[TBL] [Abstract][Full Text] [Related]
6. High-throughput fragment screening by affinity LC-MS.
Duong-Thi MD; Bergström M; Fex T; Isaksson R; Ohlson S
J Biomol Screen; 2013 Feb; 18(2):160-71. PubMed ID: 22983162
[TBL] [Abstract][Full Text] [Related]
7. Fragment screening by weak affinity chromatography: comparison with established techniques for screening against HSP90.
Meiby E; Simmonite H; le Strat L; Davis B; Matassova N; Moore JD; Mrosek M; Murray J; Hubbard RE; Ohlson S
Anal Chem; 2013 Jul; 85(14):6756-66. PubMed ID: 23806099
[TBL] [Abstract][Full Text] [Related]
8. Target immobilization as a strategy for NMR-based fragment screening: comparison of TINS, STD, and SPR for fragment hit identification.
Kobayashi M; Retra K; Figaroa F; Hollander JG; Ab E; Heetebrij RJ; Irth H; Siegal G
J Biomol Screen; 2010 Sep; 15(8):978-89. PubMed ID: 20817886
[TBL] [Abstract][Full Text] [Related]
9. Partial filling affinity capillary electrophoresis as a useful tool for fragment-based drug discovery: A proof of concept on thrombin.
Farcaş E; Bouckaert C; Servais AC; Hanson J; Pochet L; Fillet M
Anal Chim Acta; 2017 Sep; 984():211-222. PubMed ID: 28843566
[TBL] [Abstract][Full Text] [Related]
10. Comparison of weak affinity chromatography and surface plasmon resonance in determining affinity of small molecules.
Duong-Thi MD; Bergström G; Mandenius CF; Bergström M; Fex T; Ohlson S
Anal Biochem; 2014 Sep; 461():57-9. PubMed ID: 24915639
[TBL] [Abstract][Full Text] [Related]
11. Fragment-based drug discovery using rational design.
Jhoti H
Ernst Schering Found Symp Proc; 2007; (3):169-85. PubMed ID: 18510103
[TBL] [Abstract][Full Text] [Related]
12. Fragment based drug design: from experimental to computational approaches.
Kumar A; Voet A; Zhang KY
Curr Med Chem; 2012; 19(30):5128-47. PubMed ID: 22934764
[TBL] [Abstract][Full Text] [Related]
13. Cyclin G-associated kinase (GAK) affinity and antiviral activity studies of a series of 3-C-substituted isothiazolo[4,3-b]pyridines.
Wouters R; Pu SY; Froeyen M; Lescrinier E; Einav S; Herdewijn P; De Jonghe S
Eur J Med Chem; 2019 Feb; 163():256-265. PubMed ID: 30529544
[TBL] [Abstract][Full Text] [Related]
14. Fragment-based lead generation: identification of seed fragments by a highly efficient fragment screening technology.
Neumann L; Ritscher A; Müller G; Hafenbradl D
J Comput Aided Mol Des; 2009 Aug; 23(8):501-11. PubMed ID: 19533372
[TBL] [Abstract][Full Text] [Related]
15. Fragment-based drug design: computational & experimental state of the art.
Hoffer L; Renaud JP; Horvath D
Comb Chem High Throughput Screen; 2011 Jul; 14(6):500-20. PubMed ID: 21521152
[TBL] [Abstract][Full Text] [Related]
16. Fragments: where are we now?
Osborne J; Panova S; Rapti M; Urushima T; Jhoti H
Biochem Soc Trans; 2020 Feb; 48(1):271-280. PubMed ID: 31985743
[TBL] [Abstract][Full Text] [Related]
17.
de Souza Neto LR; Moreira-Filho JT; Neves BJ; Maidana RLBR; Guimarães ACR; Furnham N; Andrade CH; Silva FP
Front Chem; 2020; 8():93. PubMed ID: 32133344
[TBL] [Abstract][Full Text] [Related]
18. Target-based drug discovery: the emerging success of frontal affinity chromatography coupled to mass spectrometry.
Calleri E; Temporini C; Caccialanza G; Massolini G
ChemMedChem; 2009 Jun; 4(6):905-16. PubMed ID: 19378293
[TBL] [Abstract][Full Text] [Related]
19. Fragment-based drug discovery-the importance of high-quality molecule libraries.
Bon M; Bilsland A; Bower J; McAulay K
Mol Oncol; 2022 Nov; 16(21):3761-3777. PubMed ID: 35749608
[TBL] [Abstract][Full Text] [Related]
20. Establish an automated flow injection ESI-MS method for the screening of fragment based libraries: Application to Hsp90.
Riccardi Sirtori F; Caronni D; Colombo M; Dalvit C; Paolucci M; Regazzoni L; Visco C; Fogliatto G
Eur J Pharm Sci; 2015 Aug; 76():83-94. PubMed ID: 25952103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
